Antman Elliott M
Harvard Medical School, and the Coronary Care Unit, Samuel A Levine Cardiac Unit, Brigham and Women's Hospital, Boston, Mass, USA.
Am Heart J. 2003 Oct;146(4 Suppl):S18-22. doi: 10.1016/j.ahj.2003.09.001.
In 2002, the American College of Cardiology and the American Heart Association published an update to their guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. These revised guidelines make specific recommendations regarding the use of glycoprotein IIb/IIIa inhibitors. This article briefly reviews the evidence supporting the use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-segment elevation myocardial infarction, before moving on to discuss interpretation of these new guidelines.
2002年，美国心脏病学会和美国心脏协会发布了关于不稳定型心绞痛和非ST段抬高型心肌梗死患者管理指南的更新版。这些修订后的指南对糖蛋白IIb/IIIa抑制剂的使用提出了具体建议。在继续讨论这些新指南的解读之前，本文简要回顾了支持在不稳定型心绞痛和非ST段抬高型心肌梗死中使用糖蛋白IIb/IIIa抑制剂的证据。
